Symbiotec Pharmalab
Ticker > Company >

Symbiotec Pharmalab share price

Symbiotec Pharmalab Ltd.

 369   0   0

The company is currently not listed and is under IPO, so all the data might not be available.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Ratios

Sales Growth

1 Year19.52%
3 Year2.65%
5 Year5%

Profit Growth

1 Year492.54%
3 Year-13.11%
5 Year14.05%

ROE%

1 Year12.41%
3 Year6.13%
5 Year11.61%

ROCE %

1 Year15.75%
3 Year9.24%
5 Year14.76%

Debt/Equity

0.0679

Price to Cash Flow

0

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0

 Strengths

  • The company has significantly decreased its debt by 55.55 Cr.
  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of 0 days.

 Limitations

  • The company has shown a poor profit growth of -13.1052664029927% for the Past 3 years.
  • The company has shown a poor revenue growth of 2.64518595561334% for the Past 3 years.
  • Company has a poor ROE of 6.12866666666667% over the past 3 years.
  • The company has a low EBITDA margin of 0% over the past 5 years.

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 531.19 622.86 633.85 563.59 673.61
Total Expenditure 411.8 420.5 528.55 483.49 530.67
Operating Profit 119.39 202.37 105.3 80.09 142.94
Other Income 3.17 9.01 5.65 12.37 19.76
Interest 10.61 6.52 3.07 8.05 7.54
Depreciation 21.16 22.18 25.11 27.62 37.26
Exceptional Items 0 0 0 -64.57 0
Profit Before Tax 90.79 182.67 82.77 -7.78 117.9
Tax 18.27 47.11 21.04 14.88 28.95
Net Profit 72.52 135.56 61.73 -22.66 88.95
Adjusted EPS (Rs.) 13.26 24.79 11.29 -4.14 16.27

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 10.94 10.94 10.94 10.94 10.94
Total Reserves 486.9 622.42 684.25 661.88 750.2
Borrowings 2.47 1.46 0.73 1.41 1.12
Other N/C liabilities 20.7 25.5 26.42 26.71 26.28
Current liabilities 248.56 181.55 172.15 214.19 298.66
Total Liabilities 769.55 841.87 894.48 915.12 1087.19
Assets
Net Block 229.62 247.58 266.09 265.65 323.82
Capital WIP 28.15 26.73 22.62 73.9 19.36
Intangible WIP 2.35 0 0 0 0
Investments 107.1 122.15 130.17 65.6 42.25
Loans & Advances 8.92 30.57 57.48 123.33 200.93
Other N/C Assets 2.32 2.37 2.51 0.01 2.54
Current Assets 391.1 412.46 415.62 386.62 498.29
Total Assets 769.55 841.87 894.48 915.12 1087.19
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2023 Mar 2024
Profit from operations -7.78 117.9
Adjustment 91.15 25.36
Changes in Assets & Liabilities 25.8 39.29
Tax Paid -15.82 -35.09
Operating Cash Flow 93.35 147.46
Investing Cash Flow -132.5 -80.8
Financing Cash Flow 36.53 -62.98
Net Cash Flow -2.62 3.67

Corporate Actions

Last Updated on:
Brief about Symbiotec Pharmalab
X